References
- SimoensSCost-effectiveness of pharmacotherapy for COPD in ambulatory care: a reviewJ Eval Clin Pract20131961004101123590144
- VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
- RepapiESayersIWainLVWellcome Trust Case Control Consortium; NSHD Respiratory Study Team. Genome-wide association study identifies five loci associated with lung functionNat Genet2010421364420010834
- AlbertRKConnettJBaileyWCCOPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
- AgustiACalverleyPMCelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
- ZhangWJDingWJiangHZhangYFZhangJLNational representation in the plastic and reconstructive surgery literature: a bibliometric analysis of highly cited journalsAnn Plast Surg201370223123422156891
- YeSXingRLiuJXingFBibliometric analysis of Nobelists’ awards and landmark papers in physiology or medicine during 1983–2012Ann Med201345853253824195599
- WiysongeCSUthmanOANdumbePMHusseyGDA bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974BMC Med2013116623497441
- WhippleECDixonBEMcGowanJJLinking health information technology to patient safety and quality outcomes: a bibliometric analysis and reviewInform Health Soc Care201338111422657387
- UgoliniDNeriMCesarioAScientific production in cancer rehabilitation grows higher: a bibliometric analysisSupport Care Cancer20122081629163821881910
- UgoliniDNeriMCasilliCA bibliometric analysis of scientific production in mesothelioma researchLung Cancer201070212913520170978
- SunGHBibliometric analysis of health services research in otolaryngology journalsOtolaryngol Head Neck Surg2012147584184722807485
- RenYWangQJTianLWangCCuiSZhangJBibliometric analysis on lung cancer in China during the period of 2001–2010Thoracic Cancer201234363366
- NykiforukCIOslerGEViehbeckSThe evolution of smoke-free spaces policy literature: a bibliometric analysisHealth Policy20109711720381188
- MonyPKSrinivasanKA bibliometric analysis of published noncommunicable disease research in IndiaIndian J Med Res201113423223421911977
- CheekJGarnhamBQuanJWhat’s in a number? Issues in providing evidence of impact and quality of research(ers)Qual Health Res200616342343516449691
- JoyceCWKellyJCSugrueCA bibliometric analysis of the 100 most influential papers in burnsBurns2014401303724309203
- HeinemannMKEditor’s commentaryThorac Cardiovasc Surg201159211421500399
- GlanvilleJKendrickTMcNallyRCampbellJHobbsFDResearch output on primary care in Australia, Canada, Germany, the Netherlands, the United Kingdom, and the United States: bibliometric analysisBMJ2011342d102821385804
- D’ArcangeloDGiampietriCFacchianoFFacchianoABAMM: a preliminary bibliometric analysis on melanoma manuscriptsPigment Cell Melanoma Res201326341541723441651
- CummingsGBiondoPDCampbellDCan the global uptake of palliative care innovations be improved? Insights from a bibliometric analysis of the Edmonton Symptom Assessment SystemPalliat Med2011251718220847088
- CohenJEChaitonMOPlaninacLCTaking stock a bibliometric analysis of the focus of tobacco research from the 1980s to the 2000sAm J Prev Med201039435235620837286
- RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
- HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
- HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- MarquisKDebigaréRLacasseYMidthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166680981312231489
- MoedHFNew developments in the use of citation analysis in research evaluationArch Immunol Ther Exp (Warsz)2009571131819219533
- NielsenFEPublication outcome of research funding by the Danish Heart Foundation 1988–1990Ugeskr Laeger19981603246444648 Danish9719746
- MarxWSchierHWanitschekMCitation analysis using online databases: feasibilities and shortcomingsScientometrics20015215982
- GarfieldE100 citation classics from the Journal of the American Medical AssociationJAMA1987257152593537352
- HallGMBJA citation classics 1945–1992Br J Anaesth1998801469505768
- SeglenPOWhy the impact factor of journals should not be used for evaluating researchBMJ199731470794985029056804
- CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
- CalverleyPMAAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
- AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
- SiafakasNMVermeirePPrideNBOptimal assessment and management of chronic obstructive pulmonary disease (COPD)Eur Respir J199588139814207489808
- BrochardLManceboJWysockiMNoninvasive ventilation for acute exacerbations of chronic obstructive pulmonary diseaseN Engl J Med1995333138178227651472
- KeatingsVMCollinsPDScottDMBarnesPJDifferences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med199615325305348564092
- SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
- BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ200032072451297130310807619
- TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- BarnesPJChronic obstructive pulmonary diseaseN Engl J Med2000343426928010911010
- GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
- BarnesPJShapiroSDPauwelsRAChronic obstructive pulmonary disease: molecular and cellular mechanismsEur Respir J200322467268814582923
- CooperJDTrulockEPTriantafillouANBilateral pneumectomy (volume reduction) for chronic obstructive pulmonary diseaseJ Thorac Cardiovasc Surg19951091106116 discussion 116–1197815786
- CalverleyPPauwelsRVestboJTRial of Inhaled STeroids ANd long-acting beta2 agonists study groupCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- BuistASMcBurnieMAVollmerWMBOLD Collaborative Research GroupInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
- PauwelsRALöfdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med1999340251948195310379018
- ScholsAMSlangenJVolovicsLWoutersEFWeight loss is a reversible factor in the prognosis of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981576 Pt 1179117979620907
- RiesALKaplanRMLimbergTMPrewittLMEffects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary diseaseAnn Intern Med1995122118238327741366
- RepineJEBastALankhorstIThe Oxidative Stress Study GroupOxidative stress in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199715623413579279209
- CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
- ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
- RahmanIMorrisonDDonaldsonKMacNeeWSystemic oxidative stress in asthma, COPD, and smokersAm J Respir Crit Care Med19961544 Pt 1105510608887607
- SethiSEvansNGrantBJMurphyTFNew strains of bacteria and exacerbations of chronic obstructive pulmonary diseaseN Engl J Med2002347746547112181400
- PlantPKOwenJLElliottMWEarly use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trialLancet200035592191931193510859037
- SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
- SeemungalTARDonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
- AltoseMDRedlineSDeitzCDEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med2000343261902190911136260
- VestboJSørensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet199935391671819182310359405
- VinckenWvan NoordJAGreefhorstAPDutch/Belgian Tiotropium Study GroupImproved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J200219220921611871363
- GosselinkRTroostersTDecramerMPeripheral muscle weakness contributes to exercise limitation in COPDAm J Respir Crit Care Med199615339769808630582
- SeemungalTHarper-OwenRBhowmikARespiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116491618162311719299
- ItoKItoMElliottWMDecreased histone deacetylase activity in chronic obstructive pulmonary diseaseN Engl J Med2005352191967197615888697
- SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
- SaettaMDi StefanoATuratoGCD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 18228269517597
- AnthonisenNRWrightECHodgkinJEPrognosis in chronic obstructive pulmonary-diseaseAm Rev Respir Dis1986133114203510578
- HoggJCPathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet2004364943570972115325838
- LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199916061856186110588597
- Soler-CataluñaJJMartinez-GarcíaMARomán SanchezPRSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
- KuwanoKBoskenCHParéPDBaiTRWiggsBRHoggJCSmall airways dimensions in asthma and in chronic obstructive pulmonary diseaseAm Rev Respir Dis19931485122012258239157
- LacasseYWongEGuyattGHKingDCookDJGoldsteinRSMeta-analysis of respiratory rehabilitation in chronic obstructive pulmonary diseaseLancet19963489035111511198888163
- SaintSBentSVittinghoffEGradyDAntibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysisJAMA1995273129579607884956
- BarnesPJImmunology of asthma and chronic obstructive pulmonary diseaseNat Rev Immunol20088318319218274560
- NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med1999340251941194710379017
- BernardSLeBlancPWhittomFPeripheral muscle weakness in patients with chronic obstructive pulmonary-diseaseAm J Respir Crit Care Med199815826296349700144
- BourbeauJJulienMMaltaisFChronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du QuébecReduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management interventionArch Intern Med2003163558559112622605
- O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
- PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171997297715665324
- KeatingsVMJatakanonAWorsdellYMBarnesPJEffects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPDAm J Respir Crit Care Med199715525425489032192
- O’DonnellDERevillSMWebbKADynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2001164577077711549531
- WiggsBRBoskenCParéPDJamesAHoggJCA model of airway narrowing in asthma and in chronic obstructive pulmonary diseaseAm Rev Respir Dis19921456125112581595987
- PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet2004364943461362015313363
- HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
- MurphyTFSethiSBacterial infection in chronic obstructive pulmonary-diseaseAm Rev Respir Dis19921464106710831416398
- McSweenyAJGrantIHeatonRKAdamsKMTimmsRMLife quality of patients with chronic obstructive pulmonary-diseaseArch Intern Med198214234734787065785
- ScholsAMSoetersPBDingemansAMMostertRFrantzenPJWoutersEFPrevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitationAm Rev Respir Dis19931475115111568484624
- CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
- BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax200055211412010639527
- LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
- AgustiAGNNogueraASauledaJSalaEPonsJBusquetsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
- TraverGAClineMGBurrowsBPredictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up studyAm Rev Respir Dis19791196895902453709
- LambertRKWiggsBRKuwanoKHoggJCParéPDFunctional significance of increased airway smooth muscle in asthma and COPDJ Appl Physiol (1985)1993746277127818365980
- WagnerPDDantzkerDRDueckRVentilation-perfusion inequality in chronic obstructive pulmonary diseaseJ Clin Invest1977592203216833271
- BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
- JonesPWBoshTKQuality of life changes in COPD patients treated with salmeterolAm J Respir Crit Care Med19971554128312899105068
- MontuschiPCollinsJVCiabattoniGExhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokersAm J Respir Crit Care Med20001623 Pt 11175117710988150
- MahlerDADonohueJFBarbeeRAEfficacy of salmeterol xinafoate in the treatment of COPDChest1999115495796510208192
- NavaSAmbrosinoNCliniENoninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trialAnn Intern Med199812897217289556465
- CazzolaMMacNeeWMartinezFJAmerican Thoracic SocietyEuropean Respiratory Society Task Force on outcomes of COPDOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
- MonsóERuizJRosellABacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brushAm J Respir Crit Care Med19951524 Pt 1131613207551388
- RenzettiADMcClementJHLittBDThe Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary diseaseAm J Med19664111151295328350
- MaltaisFSimardAASimardCJobinJDesgagnésPLeBlancPOxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPDAm J Respir Crit Care Med199615312882938542131
- WilsonDORogersRMWrightECAnthonisenNRBody weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing TrialAm Rev Respir Dis19891396143514382658702
- SeneffMGWagnerDPWagnerRPZimmermanJEKnausWAHospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary diseaseJAMA199527423185218577500534
- ScanlonPDConnettJEWallerLALung Health Study Research GroupSmoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health StudyAm J Respir Crit Care Med20001612 Pt 138139010673175
- PaggiaroPLDahleRBakranIFrithLHollingworthKEfthimiouJMulticentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet199835191057737809519948
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
- VestboJPrescottELangePAssociation of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study GroupAm J Respir Crit Care Med19961535153015358630597
- PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
- SaettaMTuratoGMaestrelliPMappCEFabbriLMCellular and structural bases of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116361304130911371392
- Di FranciaMBarbierDMegeJLOrehekJTumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19941505 Pt 1145314557952575
- ScholsAMBuurmanWAStaal van den BrekelAJDentenerMAWoutersEFEvidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary diseaseThorax19965188198248795671
- RahmanIAdcockIMOxidative stress and redox regulation of lung inflammation in COPDEur Respir J200628121924216816350
- SethiSMurphyTFBacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art reviewClin Microbiol Rev200114233636311292642
- WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
- DekhuijzenPNAbenKKDekkerIIncreased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19961543 Pt 18138168810624
- DonohueJFvan NoordJABatemanEDA 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest20021221475512114338
- NishimuraKIzumiTTsukinoMOgaTDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest200212151434144012006425
- MenezesAMPerez-PadillaRJardimJRPLATINO TeamChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
- PatelISSeemungalTAWilksMLloyd-OwenSJDonaldsonGCWedzichaJARelationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax200257975976412200518
- O’DonnellDELamMWebbKAMeasurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981585 Pt 1155715659817708
- AaronSDVandemheenKLFergussonDCanadian Thoracic Society/Canadian Respiratory Clinical Research ConsortiumTiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2007146854555517310045
- WeitzenblumEHirthCDucoloneAMirhomRRasaholinjanaharyJEhrhartMPrognostic value of pulmonary artery pressure in chronic obstructive pulmonary diseaseThorax198136107527587330793
- KannerREAnthonisenNRConnettJELung Health Study Research GroupLower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333